Algo version: 0.98b
Clal Biotechnology is listed at the TLV Exchange
Clal Biotechnology [CBI.TA]
TLV Sector: Healthcare Industry:Biotechnology

Is Clal Biotechnology stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Clal Biotechnology pays dividends. Last time was Tuesday 6th of April 2021 where the investors holding the stock on Monday 29th of March 2021 were paid ILA22.3722 per share. Over the last 1 times between 2021 and 2021, Clal Biotechnology has paid ILA22.3722 with an average of ILA22.37 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Clal Biotechnology 10 years ago, but if you had invested on Monday 25th of November 2019 when the price was ILA144.90, you would have made a loss of ILA-109.70 per share or -75.71%

Yes, the average daily trading liquidity for Clal Biotechnology is ILA154 966 thousand. You should therefore be able to get in and out of your positions relatively fast.

Clal Biotechnology has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Clal Biotechnology to be high [0.85 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.